Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
Titel:
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
Auteur:
Santos-Gallego, Carlos G. Garcia-Ropero, Alvaro Mancini, Donna Pinney, Sean P. Contreras, Johanna P. Fergus, Icilma Abascal, Vivian Moreno, Pedro Atallah-Lajam, Farah Tamler, Ronald Lala, Anu Sanz, Javier Fuster, Valentin Badimon, Juan Jose